Investing Ideas
/
Taiwanese Biotech Stocks

Taiwanese Biotech Stocks

Results

1 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

54 companies

PharmaEssentia

Market Cap: NT$178.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

6446

NT$536.00

-4.1%

65.9%

Caliway Biopharmaceuticals

Market Cap: NT$120.1b

Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease.

6919

NT$781.00

-9.9%

114.9%

Bora Pharmaceuticals

Market Cap: NT$71.2b

Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.

6472

NT$692.00

-7.7%

-9.1%

Lotus Pharmaceutical

Market Cap: NT$61.6b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

1795

NT$232.00

-7.6%

-26.9%

TTY Biopharm

Market Cap: NT$18.8b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

4105

NT$75.70

1.6%

-3.4%

Medigen Vaccine Biologics

Market Cap: NT$15.9b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

6547

NT$48.35

-8.4%

-6.7%

YungShin Global Holding

Market Cap: NT$15.7b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

3705

NT$58.80

3.7%

20.1%

Synmosa Biopharma

Market Cap: NT$14.3b

A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

4114

NT$33.95

-0.4%

-6.1%

PharmaEngine

Market Cap: NT$14.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$98.80

-4.5%

-0.2%

Handa Pharmaceuticals

Market Cap: NT$11.7b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China.

6620

NT$83.00

-4.0%

-49.5%

Standard Chemical & Pharmaceutical

Market Cap: NT$10.8b

Standard Chemical & Pharmaceutical Co. Ltd.

1720

NT$60.50

-2.7%

-7.9%

Acepodia

Market Cap: NT$10.5b

Operates as a clinical stage biotechnology company.

6976

NT$18.35

-5.9%

-36.5%

SCI Pharmtech

Market Cap: NT$9.4b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

4119

NT$78.30

-5.3%

-10.8%

Adimmune

Market Cap: NT$8.6b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

4142

NT$20.40

-4.2%

-22.9%

Formosa Laboratories

Market Cap: NT$8.2b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

4746

NT$67.80

-6.9%

-41.8%

Orient Pharma

Market Cap: NT$8.0b

Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.

4166

NT$35.80

-3.0%

63.5%

Mycenax Biotech

Market Cap: NT$7.8b

A contract development and manufacturing organization company, provides biopharmaceutical services and solutions for drug development and production in Taiwan, Japan, Korea, Singapore, rest of the Asia-Pacific regions, Europe, and the United States.

4726

NT$37.50

-5.1%

-4.0%

Savior Lifetec

Market Cap: NT$6.2b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

4167

NT$19.60

-5.5%

-5.1%

Sinphar PharmaceuticalLtd

Market Cap: NT$5.6b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

1734

NT$31.05

-2.7%

-8.5%

Cenra

Market Cap: NT$5.3b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

3716

NT$35.95

-3.9%

n/a

SYN-TECH Chem. & Pharm

Market Cap: NT$4.6b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$102.50

-2.8%

22.6%

Medigen Biotechnology

Market Cap: NT$4.4b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.

3176

NT$31.90

-8.5%

-18.1%

AP Biosciences

Market Cap: NT$4.4b

A clinical-stage biopharmaceutical company, researches and develops bispecific antibody drugs for unmet medical needs.

6945

NT$51.80

-3.9%

-15.5%

Orient EuroPharma

Market Cap: NT$4.3b

A pharmaceutical company, develops and manufactures drugs worldwide.

4120

NT$49.25

-1.5%

12.7%

Nang Kuang Pharmaceutical

Market Cap: NT$4.0b

Together with its subsidiary, engages in the manufacturing, processing, trading, import, and export of pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.

1752

NT$39.80

-5.8%

-14.6%

Maxigen Biotech

Market Cap: NT$3.9b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

1783

NT$43.35

-5.6%

-5.8%

HeXun Biosciences

Market Cap: NT$3.8b

Engages in the research and development of stem cell and treatments in Taiwan.

6986

NT$82.20

-3.7%

51.7%

BRIM Biotechnology

Market Cap: NT$3.5b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

6885

NT$26.15

-4.2%

-16.6%

Syngen BiotechLtd

Market Cap: NT$3.4b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

8279

NT$127.00

-1.2%

-19.6%

TCM Biotech International

Market Cap: NT$3.3b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

4169

NT$56.30

-0.4%

7.9%

Shine-On BioMedicalLtd

Market Cap: NT$3.3b

Research, develops, and manufactures anti-cancer related drug products.

6926

NT$65.90

1.1%

-0.3%

Chunghwa Chemical Synthesis & Biotech

Market Cap: NT$2.4b

Chunghwa Chemical Synthesis & Biotech Co., Ltd.

1762

NT$31.20

-6.6%

-34.5%

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.4b

Develops stem cell medicines for patients with unmet medical needs.

6704

NT$24.90

-3.5%

-28.8%

GlycoNex Incorporation

Market Cap: NT$2.3b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

4168

NT$21.55

-8.1%

-13.8%

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan and Asia.

8432

NT$52.90

-5.2%

-12.0%

Winston Medical Supply

Market Cap: NT$1.8b

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.

6817

NT$98.40

-0.5%

-23.1%

Page 1 of 2